Gender- and age-specific rates of heart failure and other adverse cardiovascular outcomes in systemic sclerosis.

Guoli Sun, Adelina Yafasova, Charlotte Andersson, John J V McMurray, Pardeep S Jhund, Kieran F Docherty, Mikkel Faurschou, Christoffer T Nielsen, Morten Schou, Gunnar H Gislason, Christian Torp-Pedersen, Emil L Fosbøl, Lars Køber, Jawad H Butt
{"title":"Gender- and age-specific rates of heart failure and other adverse cardiovascular outcomes in systemic sclerosis.","authors":"Guoli Sun,&nbsp;Adelina Yafasova,&nbsp;Charlotte Andersson,&nbsp;John J V McMurray,&nbsp;Pardeep S Jhund,&nbsp;Kieran F Docherty,&nbsp;Mikkel Faurschou,&nbsp;Christoffer T Nielsen,&nbsp;Morten Schou,&nbsp;Gunnar H Gislason,&nbsp;Christian Torp-Pedersen,&nbsp;Emil L Fosbøl,&nbsp;Lars Køber,&nbsp;Jawad H Butt","doi":"10.1093/rheumatology/keac072","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To investigate the long-term rates of heart failure (HF) and other adverse cardiovascular outcomes, including arrhythmias, myocardial infarction, ischaemic stroke, venous thromboembolism, pulmonary hypertension and pericarditis, in SSc patients according to gender and age.</p><p><strong>Methods: </strong>Using Danish nationwide registries, SSc patients (diagnosed from 1996 to 2018) were matched with four controls from the background population by gender, age and comorbidities. Cox regression was used to compare the rates of cardiovascular outcomes between SSc patients and controls and the rate of mortality between SSc patients developing HF and HF patients without SSc, according to gender and age (above/below median).</p><p><strong>Results: </strong>In total, 1569 SSc patients were matched with 6276 non-SSc controls (median age 55 years, 80.4% women, median follow-up 7.3 years). SSc had a higher rate of HF in both women [HR 2.99 (95% CI 2.18, 4.09)] and men [HR 3.01 (1.83, 4.95)] (Pinteraction = 0.88), with similar trends for other cardiovascular outcomes. SSc had a higher rate of HF in patients &lt;55 years of age [HR 4.14 (95% CI 2.54, 6.74)] and ≥55 years [HR 2.74 (1.98, 3.78)] (Pinteraction = 0.22), with similar trends for other cardiovascular outcomes. SSc patients with new-onset HF had a higher rate of mortality than HF patients without a history of SSc, irrespective of gender (Pinteraction = 0.53) and age (Pinteraction = 0.43).</p><p><strong>Conclusions: </strong>SSc was associated with higher rates of HF and other cardiovascular outcomes than matched controls, irrespective of gender and age. Among patients with new-onset HF, a history of SSc was associated with higher mortality.</p>","PeriodicalId":379078,"journal":{"name":"Rheumatology (Oxford, England)","volume":" ","pages":"4374-4383"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rheumatology (Oxford, England)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/rheumatology/keac072","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To investigate the long-term rates of heart failure (HF) and other adverse cardiovascular outcomes, including arrhythmias, myocardial infarction, ischaemic stroke, venous thromboembolism, pulmonary hypertension and pericarditis, in SSc patients according to gender and age.

Methods: Using Danish nationwide registries, SSc patients (diagnosed from 1996 to 2018) were matched with four controls from the background population by gender, age and comorbidities. Cox regression was used to compare the rates of cardiovascular outcomes between SSc patients and controls and the rate of mortality between SSc patients developing HF and HF patients without SSc, according to gender and age (above/below median).

Results: In total, 1569 SSc patients were matched with 6276 non-SSc controls (median age 55 years, 80.4% women, median follow-up 7.3 years). SSc had a higher rate of HF in both women [HR 2.99 (95% CI 2.18, 4.09)] and men [HR 3.01 (1.83, 4.95)] (Pinteraction = 0.88), with similar trends for other cardiovascular outcomes. SSc had a higher rate of HF in patients <55 years of age [HR 4.14 (95% CI 2.54, 6.74)] and ≥55 years [HR 2.74 (1.98, 3.78)] (Pinteraction = 0.22), with similar trends for other cardiovascular outcomes. SSc patients with new-onset HF had a higher rate of mortality than HF patients without a history of SSc, irrespective of gender (Pinteraction = 0.53) and age (Pinteraction = 0.43).

Conclusions: SSc was associated with higher rates of HF and other cardiovascular outcomes than matched controls, irrespective of gender and age. Among patients with new-onset HF, a history of SSc was associated with higher mortality.

系统性硬化症患者心力衰竭和其他不良心血管结局的性别和年龄特异性发生率。
目的:根据性别和年龄,探讨SSc患者心衰(HF)及心律失常、心肌梗死、缺血性脑卒中、静脉血栓栓塞、肺动脉高压、心包炎等心血管不良结局的长期发生率。方法:使用丹麦全国注册中心,将1996年至2018年诊断的SSc患者与来自背景人群的4名对照者按性别、年龄和合并症进行匹配。根据性别和年龄(高于/低于中位数),采用Cox回归比较SSc患者和对照组之间的心血管结局率,以及SSc患者发生HF和不伴有SSc的HF患者之间的死亡率。结果:共有1569例SSc患者与6276例非SSc对照(中位年龄55岁,80.4%为女性,中位随访7.3年)。SSc患者女性和男性的HF发生率均较高[HR 2.99 (95% CI 2.18, 4.09)] (p - interaction = 0.88),其他心血管结局的趋势相似。SSc患者在55岁以下[HR 4.14 (95% CI 2.54, 6.74)]和≥55岁[HR 2.74(1.98, 3.78)]的HF发生率较高(p - interaction = 0.22),其他心血管结局的趋势相似。SSc合并新发HF患者的死亡率高于无SSc病史的HF患者,与性别(p交互作用= 0.53)和年龄(p交互作用= 0.43)无关。结论:与匹配的对照组相比,SSc与更高的HF发生率和其他心血管结局相关,与性别和年龄无关。在新发心衰患者中,SSc病史与较高的死亡率相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书